Korean J Med.
2006 Jul;71(1):86-90.
Diffuse alveolar damage during chemotherapy with oxaliplatin, 5-fluorouracil and leucovorin
- Affiliations
-
- 1Department of Internal Medicine, College of Medicine, Korea University, Seoul, Korea. chepraxis@korea.com
- 2Department of Pathology, College of Medicine, Korea University, Seoul, Korea.
Abstract
-
The combination chemotherapy of oxaliplatin with 5-fluorouracil and leucovorin (FOLFOX regimen) has been recently proved to be beneficial in advanced colorectal and gastric cancer. Side effects of this regimen include neutropenia, diarrhea, and neurosensory toxicity. However, the case reports about pulmonary toxicities of this regimen are very limited. Herein is the reported case of a patient treated with oxaliplatin, 5-fluorouracil and leucovorin combination chemotherapy in whom diffuse alveolar damage developed and the disease improved after steroid pulse therapy.